Diseases, Conditions, Syndromes
T-cells with a license to kill viruses
A research group led by Kyoto University has produced the world's first pluripotent stem cell-derived killer T-cell drug to treat COVID-19. The University has filed a patent application ahead of full-scale drug development.
Aug 2, 2024
0
28
